Abbott Laboratories Second-Quarter Results Beat Expectations Despite Lower COVID-19 Testing Sales
The company now anticipates about $1.3 billion in sales from COVID-19 testing products for 2023, compared with the prior forecast of $1.5 billion, "due to current testing dynamics, including lower demand for testing following the end of the public health emergency in...
Abbott Labratories - 30d expiry - We look to Buy a break of 109.51 (stop at 106.31)
The primary trend remains bullish.
This stock has seen good sales growth.
Expect trading to remain mixed and volatile.
109.34 has been pivotal.
Posted a bullish Flag formation.
A break of 109.34 is needed to confirm the outlook.
The bias is to break to the upside.
Our...
If you haven`t bought ABT here:
Then analyzing the options chain of ABT Abbott Laboratories prior to the earnings report this week,
I would consider purchasing the 108usd strike price in the money Puts with
an expiration date of 7/21/2023,
for a premium of approximately $2.55.
If these options prove to be profitable prior to the earnings release, I would sell at...
I like the double bottom ABT just completed. RSI is trending up. The pullback over the last week was on decreasing volume. Looking for a leg up from here.
Based on our team's research of the options market, we expect buy activity at the support level or sell activity at the resistance.
We do research and find new opportunities every day.
Please feel free to leave any comments you have and like this idea if you agree with us. Any feedback or comments will be read. We appreciate it all.
ABT is Abbott Labs, a well-established medical technology company has had good earnings
twice this year. In the first episode, the price trended down then recovered in a retracement.
I have anchored a long-term mean VWAP and its standard deviations as a means to assess
areas of dynamic support and resistance. One week ago, the price crossed the mean VWAP...
ABT is shown on a 4H chart as setting up for a short trade.
Demand and Summply Zones are charted by the LuxAlgo indicator.
Price touched the supply zone five times in December- January then
descended and touched the demand zone several times in
mid-March.
Fundamentally, earnings reports have been solid. Medical stocks
are generally independent of the...
The PEAD projected a bullish outlook for NYSE:ABT after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 84.62%.
ABT had exhibited great momentum for the past few weeks with the recent earnings on 19 Apr propelling it to gap up on high volume.
It appears to be forming a bull pennant right now. It is possible to trade the breakup of this pennant (initial stop just below the gap up candle), however bear in mind that the overhead resistance at 114 - 116 might be difficult to...
Analyzing the options chain of ABT Abbott Laboratories prior to the earnings report this week, I would consider purchasing
Calls with a 105usd strike price and an expiration date of 2023-5-19, for a premium of approximately $2.48.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
I am interested to hear...
A collection of confluent clues. 0.786 retrace on A, quadruple pincers, low volume, RSX OBOS probably peaking, P/C ratio momentally toward green. Swing low within significant count of swing high (? Fib 1:1 ratio timewise). If it doesn't swing, stop loss is close and will not break this bank.
We are not in the business of getting every prediction right, no one...
Hello dear Traders,
Here is my idea for #WMT
Price closed above yellow line
Targets marked in the chart
Invalidation level marked with red line
IV30 % Rank: 0% Subdued
Good luck!
❤️Please feel free to ask any question in comments. I will try to answer all! Thank you.
Please, support my work with like, thank you!❤️
RULES:
-If price break Point 2, 4, 6, or 8 cancel the setup
-Price needs to break Point 1, 3, 5, or 7 to confirm the setup
When price reach the 100FE(BLUE BOX) it normally does a pullback/retest or reversal
The market can Truncate(fall short)
The PEAD projected a Bullish outlook for $ABT after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 42.86%.
This is a very simple and straight forward analysis in which there is an impulse and a correction.
.
it has broken out of the correction and also the resistance line
The PEAD projected a Bullish outlook for $ABT after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 100%.
